GlassScriptPhysician profile
Kevin R Kellogg
NPI 1457380941
$3,807.75
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
See the full distribution for Sleep Medicine (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,798 · 2020: $1,993 · 2022: $17.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $877.43 | 2019-2020 | |
| Ucb, INC. | $425.40 | 2019-2022 | |
| Biogen, INC. | $329.44 | 2019-2020 | |
| Genzyme Corporation | $264.55 | 2019-2020 | |
| Harmony Biosciences LLC | $250.38 | 2020 | |
| Supernus Pharmaceuticals, INC. | $162.72 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $160.58 | 2019-2020 | |
| Amgen INC. | $137.30 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $135.06 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $132.47 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $122.11 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $113.10 | 2019-2020 | |
| Greenwich Biosciences, INC. | $102.29 | 2019 | |
| Lilly USA, LLC | $102.21 | 2019-2020 | |
| Csl Behring | $69.26 | 2019-2020 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $64.37 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $46.79 | 2019 | |
| Eisai INC. | $43.51 | 2020 | |
| Sk Life Science, INC. | $36.74 | 2020 | |
| Janssen Pharmaceuticals, INC | $28.67 | 2020 | |
| Neurelis, INC. | $27.24 | 2020 | |
| Kyowa Kirin, INC. | $26.88 | 2019-2020 | |
| Allergan, INC. | $26.75 | 2020 | |
| Upsher-Smith Laboratories LLC | $21.19 | 2020 | |
| Neurocrine Biosciences, INC. | $19.51 | 2020 | |
| Tanabe Pharma America, INC. | $19.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.19 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.11 | 2020 | |
| Genentech USA, INC. | $14.84 | 2020 | |
| Alnylam Pharmaceuticals INC. | $14.31 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Kellogg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.